Company profile

Marker Therapeutics, Inc. insider acquisitions

Company CIK 0001094038 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
MRKR · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

8 dated transactions · 5 of 5 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 17, 2025Marker Therapeutics, Inc.Stock Option (Right to Buy)Knobil KatharineStock award
Nov 17, 2025Marker Therapeutics, Inc.Stock Option (Right to Buy)Knobil KatharineStock award
Nov 17, 2025Marker Therapeutics, Inc.Stock Option (Right to Buy)Eansor Norman DavidStock award
Nov 17, 2025Marker Therapeutics, Inc.Stock Option (Right to Buy)Eansor Norman DavidStock award
Nov 17, 2025Marker Therapeutics, Inc.Stock Option (right to buy)ELMS STEVEStock award
Nov 17, 2025Marker Therapeutics, Inc.Stock Option (right to buy)ELMS STEVEStock award
Oct 31, 2025Marker Therapeutics, Inc.Stock Option (Right to Buy)Corzo Kathryn PenkusStock award
Oct 31, 2025Marker Therapeutics, Inc.Employee Stock Option (right to buy)Vera JuanStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

MRKR · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A137,3300Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A84,4110Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A137,3300Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A84,4110Value: 0Currency not specifiedView ↗
Trade:
ELMS STEVEDirector
Stock awardStock Option (right to buy)Derivative security · Code A137,3300Value: 0Currency not specifiedView ↗
Trade:
ELMS STEVEDirector
Stock awardStock Option (right to buy)Derivative security · Code A84,4110Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A147,6110Value: 0Currency not specifiedView ↗
Trade:
Vera JuanChief Executive Officer · Director
Stock awardEmployee Stock Option (right to buy)Derivative security · Code A250,0000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →